No connection

Search Results

COMP

BEARISH
$7.85 Live
Compass, Inc. · NYSE
Target $13.25 (+68.8%)
$5.66 52W Range $13.96

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$5.86B
P/E
N/A
ROE
-9.8%
Profit margin
-0.8%
Debt/Equity
0.6
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Compass, Inc. exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, placing it in the 'Weak' health category. While the company maintains strong top-line revenue growth of 23.10% and a low Price/Sales ratio of 0.84, these are offset by negative profit margins, a negative ROE of -9.79%, and a concerning liquidity position with a current ratio of 0.86. There is a stark disconnect between the bullish analyst target price of $13.25 and the internal reality of consistent earnings misses (0/4 beats in the last year) and aggressive insider selling by the CFO and General Counsel.

Key Strengths

Strong YoY revenue growth of 23.10%
Attractive Price/Sales ratio (0.84) suggesting undervaluation relative to sales
Moderate Debt/Equity ratio of 0.60
Strong analyst support with a 'Buy' consensus and target price of $13.25
Significant market capitalization providing some scale in the real estate services industry

Key Risks

Weak financial health as indicated by a Piotroski F-Score of 3/9
Liquidity risk with a current ratio (0.86) and quick ratio (0.77) below 1.0
Persistent lack of profitability with negative profit and operating margins
Severe earnings deterioration with YoY EPS growth at -600%
Bearish insider sentiment with multiple sales by the CFO and General Counsel
AI Fair Value Estimate
Based on comprehensive analysis
$6.5
-17.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
29
Weak
Value
45
Future
50
Past
30
Health
20
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score (3/9), Negative ROE/Margins, Insider Selling, Liquidity Shortfall
Confidence
90%
Value
45/100

Trades at a low multiple of sales, but lacks the earnings to support a traditional P/E valuation.

Positives
  • Low P/S ratio
  • Low Forward P/E
Watchpoints
  • High Price/Book (5.66)
  • Lack of current earnings
Future
50/100

Growth is occurring in revenue but not translating to the bottom line.

Positives
  • Consistent revenue growth > 23%
Watchpoints
  • Crashing EPS growth
  • Failure to beat earnings estimates
Past
30/100

Long-term shareholders have seen significant value erosion.

Positives
  • 3Y recovery trend
Watchpoints
  • 5Y change of -56.4%
  • Consistent earnings misses
Health
20/100

Deterministic health scores indicate a weak financial foundation and liquidity pressure.

Positives
  • Manageable Debt/Equity
Watchpoints
  • Piotroski Score 3/9
  • Current Ratio < 1.0
  • Negative ROA
Dividend
0/100

Non-dividend paying growth/turnaround stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 strength score

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$7.85
Analyst Target
$13.25
Upside/Downside
+68.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for COMP and closest competitors.

Updated 2026-04-24
COM
Compass, Inc.
Primary
5Y
-56.4%
3Y
+204.3%
1Y
+6.7%
6M
-2.2%
1M
-0.9%
1W
-3.6%
CIG
Colliers International Group Inc.
Peer
5Y
+6.7%
3Y
+10.1%
1Y
-2.1%
6M
-28.9%
1M
-8.4%
1W
+1.1%
PEC
Phillips Edison & Company, Inc.
Peer
5Y
+695.5%
3Y
+36.7%
1Y
+13.4%
6M
+16.3%
1M
+2.7%
1W
+1.0%
SBR
Sabra Health Care REIT, Inc.
Peer
5Y
+73.9%
3Y
+131.3%
1Y
+21.6%
6M
+17.7%
1M
+0.2%
1W
+1.1%
FSV
FirstService Corporation
Peer
5Y
-4.5%
3Y
+5.8%
1Y
-12.7%
6M
-20.5%
1M
-2.3%
1W
+4.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
9.11
PEG Ratio
N/A
P/B Ratio
5.66
P/S Ratio
0.84
EV/Revenue
0.88
EV/EBITDA
80.39
Market Cap
$5.86B

Profitability

Profit margins and return metrics

Profit Margin -0.84%
Operating Margin -1.74%
Gross Margin 12.23%
ROE -9.79%
ROA -1.26%

Growth

Revenue and earnings growth rates

Revenue Growth +23.1%
Earnings Growth N/A
Q/Q Revenue Growth +23.14%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.6
Moderate
Current Ratio
0.86
Weak
Quick Ratio
0.77
Poor
Cash/Share
$0.27

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.7B
Gross Margin
18.5%
Op. Margin
-1.7%
Net Margin
-2.5%
Total Assets
$1.5B
Liabilities
$0.8B
Equity
$0.8B
Debt/Equity
0.96x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
93%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-26
$-0.07
-18.1% surprise
2025-11-04
$0.11
-0.0% surprise
2025-07-30
$0.16
-7.6% surprise

Real Estate Sector Comparison

Comparing COMP against 128 companies in the Real Estate sector (5 bullish, 22 neutral, 101 bearish)
Return on Equity (ROE)
-9.79%
This Stock
vs
-45.04%
Sector Avg
-78.3% (Below Avg)
Profit Margin
-0.84%
This Stock
vs
9.23%
Sector Avg
-109.1% (Weaker)
Debt to Equity
0.6
This Stock
vs
2.76
Sector Avg
-78.1% (Less Debt)
Revenue Growth
23.1%
This Stock
vs
21748.67%
Sector Avg
-99.9% (Slower)
Current Ratio
0.86
This Stock
vs
9.53
Sector Avg
-90.9% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

WAHLERS SCOTT R
Chief Financial Officer
Stock Award
2026-03-23
35,460 shares
GLASS ETHAN CHARLES
Officer
Stock Award
2026-03-16
101,733 shares
WAHLERS SCOTT R
Chief Financial Officer
Stock Award
2026-03-16
56,690 shares
LEINWAND ALLAN
Director
Gift
2026-03-03
30,296 shares
REFFKIN ROBERT L.
Chief Executive Officer
Stock Award
2026-02-04
1,154,593 shares
SORDELLO STEVEN J
Director
Stock Award
2026-02-02
2,773 shares
WAHLERS SCOTT R
Chief Financial Officer
Sell
2026-01-07
99,986 shares · $1,202,602
GLASS ETHAN CHARLES
Officer
Stock Award
2026-01-06
101,732 shares
WAHLERS SCOTT R
Chief Financial Officer
Stock Award
2026-01-06
76,329 shares
WAHLERS SCOTT R
Chief Financial Officer
Sell
2025-12-17
26,600 shares · $292,600
WAHLERS SCOTT R
Chief Financial Officer
Sell
2025-12-12
23,500 shares · $258,585
SORDELLO STEVEN J
Director
Stock Award
2025-12-03
2,773 shares
SERWIN BRADLEY K.
General Counsel
Sell
2025-11-25
55,874 shares · $590,169
WAHLERS SCOTT R
Chief Financial Officer
Sell
2025-11-25
49,900 shares · $549,045
SERWIN BRADLEY K.
General Counsel
Sell
2025-11-12
1,807 shares · $16,715
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-17

COMP filed an 8-K likely announcing its first quarter financial results for 2026.

DEF 14A
DEF 14A
2026-04-03

COMP filed its definitive proxy statement on April 3, 2026, providing shareholders with necessary information and voting materials for the upcoming annual meeting.

10-K
10-K
2026-02-27

COMP submitted its annual 10-K filing on February 27, 2026. The provided excerpts do not contain specific financial highlights or detailed risk factors.

8-K
8-K
2026-02-26

COMP filed an 8-K on February 26, 2026, likely to announce its fourth-quarter and full-year financial results.

8-K
8-K
2026-02-23

COMP filed an 8-K on February 23, 2026, likely to announce its annual financial results.

8-K/A
8-K/A
2026-02-09

COMP filed an amendment to a previously submitted Form 8-K on February 9, 2026.

8-K
8-K
2026-01-09
8-K
8-K
2026-01-08
8-K
8-K
2026-01-07
8-K
8-K
2026-01-07
8-K
8-K
2025-12-29
8-K
8-K
2025-11-17
10-Q
10-Q
2025-11-05
8-K
8-K
2025-11-04
8-K
8-K
2025-09-22
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
12 analysts
Barclays
2026-04-08
Maintains
Overweight Overweight
Wells Fargo
2026-04-06
Maintains
Equal-Weight Equal-Weight
Benchmark
2026-03-26
init
Buy
JP Morgan
2026-01-26
init
Overweight
Barclays
2026-01-15
Maintains
Overweight Overweight
Wells Fargo
2026-01-13
Maintains
Equal-Weight Equal-Weight
BTIG
2026-01-08
Maintains
Buy Buy
Barclays
2025-12-08
up
Equal-Weight Overweight
BTIG
2025-11-25
Maintains
Buy Buy
UBS
2025-11-05
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning COMP from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile